ATNF

180 Life Sciences Corp. [ATNF] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ATNF Stock Summary

Top 10 Correlated Stocks

ATNF


In the News

08:06 28 Mar 2024 ATNF

Why Is 180 Life Sciences (ATNF) Stock Up 38% Today?

180 Life Sciences (NASDAQ: ATNF ) stock is climbing higher on Wednesday as the cannabis market undergoes a rally. The cannabis sector has been on the rise lately as several companies in it release earnings reports.

06:00 28 Mar 2024 ATNF

Penny Stock Investing, 3 High-Growth Industries to Watch

Take a look at these 3 industries to find penny stocks in The post Penny Stock Investing, 3 High-Growth Industries to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

12:57 28 Mar 2024 ATNF

5 Top Penny Stocks To Watch Today; Time To Buy?

5 hot penny stocks to watch right now. The post 5 Top Penny Stocks To Watch Today; Time To Buy?

06:00 28 Mar 2024 ATNF

Using News to Find Penny Stocks to Buy: 3 Tips

Are you using the news to find penny stocks to buy? The post Using News to Find Penny Stocks to Buy: 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

12:27 28 Mar 2024 ATNF

Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch

Short squeeze penny stocks to watch this week. The post Penny Stocks To Buy This Week?

11:00 28 Mar 2024 ATNF

3 Essential Strategies for Penny Stocks Trading in 2023

Are you using these penny stocks trading strategies? The post 3 Essential Strategies for Penny Stocks Trading in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

04:27 28 Mar 2024 ATNF

The 7 Most Sold-Off Stocks of 2022

With a contentious time in 2022 coming to a close, it may be helpful to look back and consider the most sold-off stocks last year. Similar to learning from prior mistakes, investors may be able to garner lessons from the worst-hit market ideas.

08:43 28 Mar 2024 ATNF

180 Life Sciences (ATNF) Stock: 1-For-20 Reverse Split Goes Into Effect

A 1-for-20 reverse split of 180 Life Sciences (ATNF) stock has gone into effect. These are the details.

08:28 28 Mar 2024 ATNF

Why 180 Life Sciences Shares Are Plunging Today

180 Life Sciences Corp (NASDAQ: ATNF) received a written response from the U.K.'s regulatory agency and U.S. FDA related to questions submitted in a Type C meeting request for anti-TNF treatment, adalimumab, to treat early-stage Dupuytren's disease. Dupuytren's disease.

08:31 28 Mar 2024 ATNF

180 Life Sciences (ATNF) Stock: Why The Price Jumped Up Today

The stock price of 180 Life Sciences Corp (NASDAQ: ATNF) increased by over 11% pre-market today. This is why it happened.

ATNF Financial details

Company Rating
Sell
Market Cap
2.36M
Income
-40.42M
Revenue
0
Book val./share
-0.02
Cash/share
0.33
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
29 Mar 2024
P/E
-0.04
Forward P/E
-0.04
PEG
-1.3
P/S
-
P/B
-11.7
P/C
6.09
P/FCF
-0.19
Quick Ratio
0.58
Current Ratio
0.7
Debt / Equity
-2.38
LT Debt / Equity
-0.15
-
-
EPS (TTM)
-13
EPS next Y
-57
EPS next Q
1.58
EPS this Y
57.25%
EPS next Y
338.46%
EPS next 5Y
-538.46%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
84.29%
-
-
-
-
SMA20
-22.28%
SMA50
-30.07%
SMA100
-65.54%
Inst Own
34102.4%
Inst Trans
0.84%
ROA
-815%
ROE
-645%
ROC
-116.8%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
852.76K
Shs Float
809.18K
-
-
-
-
Target Price
-
52W Range
2.6101-51.3
52W High
-96.06%
52W Low
+0.5%
RSI
30.84
Rel Volume
2.26
Avg Volume
95.76K
Volume
216.39K
Perf Week
-40.53%
Perf Month
-49.62%
Perf Quarter
-81.74%
Perf Half Y
-81.11%
-
-
-
-
Beta
0.482
-
-
Volatility
0.61%, 0.56%
Prev Close
2.55%
Price
2.01
Change
-4.29%

ATNF Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
0-46.02-11.99-12.96-20.38
Operating cash flow per share
0-6.01-4.27-12.36-6.38
Free cash flow per share
0-6.28-4.27-12.36-6.38
Cash per share
021.682.325.253.67
Book value per share
069.933.3725.085.97
Tangible book value per share
0-22.67-23.39-7.780.33
Share holders equity per share
069.933.3725.085.97
Interest debt per share
06.735.361.370.72
Market cap
0324.99M941.65M2.32B122.4M
Enterprise value
-270.88K328.43M943.32M2.32B116.77M
P/E ratio
0-12.8-86.52-114.32-3.16
Price to sales ratio
00000
POCF ratio
0-97.93-243.2-119.94-10.09
PFCF ratio
0-93.84-243.2-119.94-10.09
P/B Ratio
08.4331.0959.0910.79
PTB ratio
08.4331.0959.0910.79
EV to sales
00000
Enterprise value over EBITDA
31.06-15.97-179.41-156.99-6.56
EV to operating cash flow
0.34-98.97-243.63-119.62-9.63
EV to free cash flow
0.34-94.84-243.63-119.62-9.63
Earnings yield
0-0.08-0.01-0.01-0.32
Free cash flow yield
0-0.010-0.01-0.1
Debt to equity
00.090.120.050.12
Debt to assets
00.070.070.030.07
Net debt to EBITDA
31.06-0.17-0.320.420.32
Current ratio
0.50.080.190.571.58
Interest coverage
0-112.69-5.2-84-671.17
Income quality
-0.760.130.360.950.31
Dividend Yield
00000
Payout ratio
00-0.0400
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00.980.930.820.55
Capex to operating cash flow
00.04000
Capex to revenue
00000
Capex to depreciation
0-2000
Stock based compensation to revenue
00000
Graham number
0269.0594.8885.5352.32
ROIC
0-0.5-0.17-0.38-1.38
Return on tangible assets
0-31.64-2.71-1.81-4.34
Graham Net
0-1.73-24.23-8.63-0.62
Working capital
-275.18K-8.89M-17.41M-8.5M3.27M
Tangible asset value
113.87M-12.51M-21.23M-12.19M622.06K
Net current asset value
-4.3M-12.57M-21.23M-12.19M622.06K
Invested capital
00.090.120.050.12
Average receivables
0164.17K556.49K739.6K657.76K
Average payables
02.05M6.32M4.56M1.19M
Average inventory
0150.78K704.45K1.67M805.65K
Days sales outstanding
00000
Days payables outstanding
020.73K24.84K1.84K6.03K
Days of inventory on hand
01.52K3.22K7.01K-2.08K
Receivables turnover
00000
Payables turnover
00.020.010.20.06
Inventory turnover
00.240.110.05-0.18
ROE
0-0.66-0.36-0.52-3.41
Capex per share
0-0.26000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-19.87-9.75-1.26-0.7-1.29
Operating cash flow per share
-1.84-1.31-1.03-0.6-0.22
Free cash flow per share
-1.84-1.31-1.03-0.6-0.22
Cash per share
1.833.120.710.380.33
Book value per share
13.315.081.911.28-0.02
Tangible book value per share
-0.890.28-0.96-0.77-0.22
Share holders equity per share
13.315.081.911.28-0.02
Interest debt per share
0.230.60.240.120.05
Market cap
495.06M143.7M128.15M116.29M92.56M
Enterprise value
491.91M138.07M126.38M114.9M90.25M
P/E ratio
-3.18-1.65-6.77-7.9-2.25
Price to sales ratio
00000
POCF ratio
-137.66-49.1-33.12-37.31-52.13
PFCF ratio
-137.66-49.1-33.12-37.31-52.13
P/B Ratio
18.9912.6717.9517.32-619.85
PTB ratio
18.9912.6717.9517.32-619.85
EV to sales
00000
Enterprise value over EBITDA
-121.54-24.64-26.43-31.44-25.75
EV to operating cash flow
-136.78-47.18-32.66-36.86-50.83
EV to free cash flow
-136.78-47.18-32.66-36.86-50.83
Earnings yield
-0.08-0.15-0.04-0.03-0.11
Free cash flow yield
-0.01-0.02-0.03-0.03-0.02
Debt to equity
0.020.120.120.09-2.38
Debt to assets
0.010.070.060.040.07
Net debt to EBITDA
0.7810.370.380.66
Current ratio
1.381.580.820.690.7
Interest coverage
-456.46-1.24K-415.7-317.33-304.12
Income quality
0.170.130.810.850.17
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.810.550.720.790.32
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
77.1333.397.364.510.74
ROIC
-0.28-0.43-0.6-0.5-14
Return on tangible assets
-5.97-2.44-1.13-1.25-3.05
Graham Net
-2.06-0.53-1.35-0.94-0.3
Working capital
1.79M3.27M-925.57K-1.34M-1.44M
Tangible asset value
-1.75M622.06K-3.59M-4.02M-1.74M
Net current asset value
-1.75M622.06K-3.59M-4.02M-1.74M
Invested capital
0.020.120.120.09-2.38
Average receivables
2.27M1.57M489.23K223.49K109.95K
Average payables
1.3M1.41M1.5M1.02M1.28M
Average inventory
-767.03K-1.57M-489.23K-223.49K-109.95K
Days sales outstanding
00000
Days payables outstanding
11.46K4.31K4.99K2.64K4.72K
Days of inventory on hand
-28.33K-1.49K-1.48K-282.08-359
Receivables turnover
00000
Payables turnover
0.010.020.020.030.02
Inventory turnover
0-0.06-0.06-0.32-0.25
ROE
-1.49-1.92-0.66-0.5568.75
Capex per share
00000

ATNF Frequently Asked Questions

What is 180 Life Sciences Corp. stock symbol ?

180 Life Sciences Corp. is a US stock , located in Palo alto of Ca and trading under the symbol ATNF

What is 180 Life Sciences Corp. stock quote today ?

180 Life Sciences Corp. stock price is $2.01 today.

Is 180 Life Sciences Corp. stock public?

Yes, 180 Life Sciences Corp. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap